The UK is seeing a burgeoning interest in mind-altering compounds , particularly copyright and Cannabigerol . Researchers are progressively examining the possibilities of these compounds for medical purposes, resulting in a evolving conversation around their regulatory position and safe use . Despite restrictions remain, the research field is passi